Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1). - Ri M; Iida S; Saito K; Saito Y; Maruyama D; Asano A; Fukuhara S; Tsujimura H; Miyazaki K; Ota S; Fukuhara N; Negoro E; et al. (Cancer chemotherapy and pharmacology, 2025)